The authors present a few actionable steps for basic, translational and clinical research communities in advancing the utility of the platelet transcriptome as a highly sensitive biomarker in cancer and collectively enable efforts toward clinical translation and patient benefit.
[British Journal of Cancer]
6445212
BBBBBBBB
items
1
apa
0
default
asc
1
169262
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/